Market Watch Highlights: Capricor Therapeutics Inc (CAPR) Ends on an Downturn Note at 15.01

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Capricor Therapeutics Inc’s stock clocked out at $15.01, down -1.31% from its previous closing price of $15.21. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 12.82 million shares were traded. CAPR stock price reached its highest trading level at $18.13 during the session, while it also had its lowest trading level at $13.77.

Ratios:

To gain a deeper understanding of CAPR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.37. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.38.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on May 17, 2024, initiated with a Outperform rating and assigned the stock a target price of $14.

On January 05, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.

On October 26, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $15.Ladenburg Thalmann initiated its Buy rating on October 26, 2022, with a $15 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.

Musket David B bought 410 shares of CAPR for $1,128 on Oct 12 ’23. The Director now owns 31,536 shares after completing the transaction at $2.75 per share. On Oct 10 ’23, another insider, COLLIER EARL M JR, who serves as the Director of the company, bought 10,000 shares for $2.83 each. As a result, the insider paid 28,300 and bolstered with 26,856 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 530414368 and an Enterprise Value of 460784128. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.99 while its Price-to-Book (P/B) ratio in mrq is 41.74. Its current Enterprise Value per Revenue stands at 16.97 whereas that against EBITDA is -16.038.

Stock Price History:

Over the past 52 weeks, CAPR has reached a high of $15.65, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is 199.35%, while the 200-Day Moving Average is calculated to be 195.19%.

Shares Statistics:

It appears that CAPR traded 1.84M shares on average per day over the past three months and 11201490 shares per day over the past ten days. A total of 31.15M shares are outstanding, with a floating share count of 27.08M. Insiders hold about 16.78% of the company’s shares, while institutions hold 19.89% stake in the company. Shares short for CAPR as of 1726185600 were 7525188 with a Short Ratio of 4.09, compared to 1723680000 on 6996266. Therefore, it implies a Short% of Shares Outstanding of 7525188 and a Short% of Float of 27.700000000000003.

Most Popular